Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Other Accumulated Expenses (2021 - 2024)

Lucid Diagnostics' Other Accumulated Expenses history spans 4 years, with the latest figure at $869000.0 for Q4 2024.

  • For Q4 2024, Other Accumulated Expenses fell 90.69% year-over-year to $869000.0; the TTM value through Dec 2024 reached $869000.0, down 90.69%, while the annual FY2024 figure was $869000.0, 90.69% down from the prior year.
  • Other Accumulated Expenses reached $869000.0 in Q4 2024 per LUCD's latest filing, up from $53000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $10.3 million in Q3 2023 to a low of $53000.0 in Q3 2024.
  • Average Other Accumulated Expenses over 4 years is $3.5 million, with a median of $1.4 million recorded in 2024.
  • Peak YoY movement for Other Accumulated Expenses: soared 834.09% in 2022, then tumbled 99.48% in 2024.
  • A 4-year view of Other Accumulated Expenses shows it stood at $531000.0 in 2021, then skyrocketed by 834.09% to $5.0 million in 2022, then soared by 88.29% to $9.3 million in 2023, then plummeted by 90.69% to $869000.0 in 2024.
  • Per Business Quant, the three most recent readings for LUCD's Other Accumulated Expenses are $869000.0 (Q4 2024), $53000.0 (Q3 2024), and $266000.0 (Q2 2024).